Patents Assigned to Protalex, Inc.
  • Protein A compositions and methods of use
    Patent number: 9370552
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: June 21, 2016
    Assignee: Protalex, Inc.
    Inventor: Paul Mann
  • PROTEIN A COMPOSITIONS AND METHODS OF USE
    Publication number: 20140093539
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Applicant: Protalex, Inc.
    Inventor: Paul Mann
  • Protein A compositions and methods of use
    Patent number: 8603486
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: December 10, 2013
    Assignee: Protalex, Inc.
    Inventor: Paul Mann
  • PROTEIN A COMPOSITIONS AND METHODS OF USE
    Publication number: 20120294895
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Application
    Filed: April 23, 2012
    Publication date: November 22, 2012
    Applicant: Protalex, Inc.
    Inventor: PAUL MANN
  • Protein A compositions and methods of use
    Patent number: 8168189
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: May 1, 2012
    Assignee: Protalex, Inc.
    Inventor: Paul Mann
  • PROTEIN A COMPOSITIONS AND METHODS OF USE
    Publication number: 20110064762
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Application
    Filed: September 14, 2010
    Publication date: March 17, 2011
    Applicant: Protalex, Inc.
    Inventor: PAUL MANN
  • Protein A compositions and methods of use
    Patent number: 7807170
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Grant
    Filed: November 14, 2006
    Date of Patent: October 5, 2010
    Assignee: Protalex, Inc.
    Inventor: Paul Mann
  • Protein A methods of use
    Patent number: 7425331
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Grant
    Filed: September 15, 2004
    Date of Patent: September 16, 2008
    Assignee: Protalex, Inc.
    Inventor: Paul Mann
  • PROTEIN A COMPOSITIONS AND METHODS OF USE
    Publication number: 20070129285
    Abstract: Methods and compositions for modulating an immune response in a subject are provided. Methods include administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor, e.g., protein A (PA), sufficient to modulate the immune response. Compositions include a lymphocyte differentiation factor, e.g., protein A (PA), in an amount less than 1 ?g.
    Type: Application
    Filed: November 14, 2006
    Publication date: June 7, 2007
    Applicant: Protalex, Inc.
    Inventor: Paul Mann
  • Protein A compositions and methods of use
    Patent number: 7211258
    Abstract: The invention provides methods for modulating an immune response in a subject including, for example, administering to the subject a composition comprising an effective amount of a lymphocyte differentiation factor sufficient to modulate the immune response. In one aspect, the lymphocyte differentiation factor comprises protein A (PA).
    Type: Grant
    Filed: April 10, 2002
    Date of Patent: May 1, 2007
    Assignee: Protalex, Inc.
    Inventor: Paul Mann